Rapport Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.0M | 202k | 29.70 |
| 2025-06-30 | $1.1M | 94k | 11.37 |
| 2025-03-31 | $912k | 91k | 10.03 |
| 2024-12-31 | $1.3M | 74k | 17.74 |
| 2024-09-30 | $1.5M | 73k | 20.48 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management